日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SLC25A42 promotes gastric cancer growth by conferring ferroptosis resistance through enhancing CPT2-mediated fatty acid oxidation.

SLC25A42 通过增强 CPT2 介导的脂肪酸氧化,赋予细胞铁死亡抵抗力,从而促进胃癌的生长

Wang Haoying, Dou Weijia, Liu Mengxiao, Wang Weifang, Yang Ying, Li Jibin, Liu Zhenxiong, Wang Nan

An investigation of the relationships between suicidal ideation, psychache, and meaning in life using network analysis

运用网络分析法研究自杀意念、心理痛苦和生命意义之间的关系

Li, Yijun; Guo, Zhihua; Tian, Wenqing; Wang, Xiuchao; Dou, Weijia; Chen, Yanfeng; Huang, Shen; Ni, Shengdong; Wang, Hui; Wang, Chaoxian; Liu, Xufeng; Zhu, Xia; Wu, Shengjun

Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling

miR-144/451a簇的表观遗传沉默通过旁分泌HGF/MIF介导的TAM重塑促进HCC进展

Zhao, Junlong; Li, Huichen; Zhao, Shoujie; Wang, Enxin; Zhu, Jun; Feng, Dayun; Zhu, Yejing; Dou, Weijia; Fan, Qingling; Hu, Jie; Jia, Lintao; Liu, Lei

The diagnostic value of the combination of Golgi protein 73, glypican-3 and alpha-fetoprotein in hepatocellular carcinoma: a diagnostic meta-analysis

高尔基蛋白73、糖蛋白聚糖-3和甲胎蛋白联合检测在肝细胞癌诊断中的价值:一项诊断荟萃分析

Zhao, Shoujie; Long, Min; Zhang, Xiangnan; Lei, Shixiong; Dou, Weijia; Hu, Jie; Du, Xilin; Liu, Lei

A comparison of transcatheter arterial chemoembolization used with and without apatinib for intermediate- to advanced-stage hepatocellular carcinoma: a systematic review and meta-analysis

比较经导管动脉化疗栓塞术联合或不联合阿帕替尼治疗中晚期肝细胞癌的疗效:系统评价和荟萃分析

Zhao, Shoujie; Zhang, Ting; Dou, Weijia; Wang, Enxin; Wang, Mengmeng; Wang, Chengguo; Du, Xilin; Liu, Lei

Analysis of the clinical efficacy of liver resection combined with adjuvant microwave coagulation for patients with hepatocellular carcinoma

分析肝切除联合辅助微波凝固治疗肝细胞癌的临床疗效

Zhang, Ting; Wang, Mengmeng; Zhang, Xiangnan; Hu, Jie; Dou, Weijia; Fan, Qingling; Feng, Dayun; Liu, Lei

Identifying optimal candidates for liver resection or transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma

确定不可切除肝细胞癌患者中适合进行肝切除术或经动脉化疗栓塞术的最佳候选者

Zhao, Shoujie; Zhang, Xiangnan; Wang, Mengmeng; Tan, Kai; Dou, Weijia; Fan, Qingling; Li, Huichen; Du, Xilin; Liu, Lei

Identifying optimal candidates of transarterial chemoembolization (TACE) vs. sorafenib in patients with unresectable hepatocellular carcinoma

确定不可切除肝细胞癌患者经动脉化疗栓塞术 (TACE) 与索拉非尼治疗的最佳候选者

Zhao, Shoujie; Dou, Weijia; Fan, Qingling; Hu, Jie; Li, Huichen; Zhang, Xiangnan; Zhang, Qian; Liu, Lei